Cryptosporidiosis in HIV/AIDS Patients in Kenya: Clinical Features, Epidemiology, Molecular Characterization and Antibody Responses-Reference-Cited by-同舟云学术

Cryptosporidiosis in HIV/AIDS Patients in Kenya: Clinical Features, Epidemiology, Molecular Characterization and Antibody Responses

Published:2014-08-06 Issue:2 Volume:91 Page:319-328
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Wanyiri Jane W.,Wamae Claire N.,Kanyi Henry,Steen Aaron,Ngugi Paul,O'Connor Roberta,Maina Samuel,Mwamburi Mkaya,Wang David E.,Ward Honorine D.,Kamau Timothy,Gachuhi Kimani,Waithera Tabitha

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference77 articles.

1. Cryptosporidiosis in patients with HIV/AIDS;O'Connor;AIDS,2011

2. Prevention and treatment of cryptosporidiosis in immunocompromised patients;Abubakar;Cochrane Database Syst Rev,2007

3. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis;Abubakar;Br J Clin Pharmacol,2007

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mendelian segregation and high recombination rates facilitate genetic analyses in Cryptosporidium parvum;PLOS Genetics;2024-06-17

2. Dendritic cell-mediated responses to secreted Cryptosporidium effectors promote parasite-specific CD8+ T cell responses;Mucosal Immunology;2024-06

3. Mendelian segregation and high recombination rates facilitate genetic analyses inCryptosporidium parvum;2024-02-02

4. Examination of ELISA against PCR for assessing treatment efficacy against Cryptosporidium in a clinical trial context;PLOS ONE;2023-09-08

5. Dendritic cell-mediated responses to secretedCryptosporidiumeffectors are required for parasite-specific CD8⁺T cell responses;2023-08-18